The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Sirio mulls to acquire 80pct stake in Best Formulations for USD180.12mln
Sirio Pharma Co., Ltd. (300791.SZ), a Chinese leading integrated contract manufacturer for the dietary supplement industry, on Thursday announced share issuance plan with the raised funds to buy 80 percent stake in Best Formulations Inc, a U.S. nutraceutical and pharmaceutical company.
July08,2022
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.